Search Results - "Sudhakar, Akulapalli"
-
1
Retraction Note: Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression
Published in Pharmaceutical research (01-02-2021)“…A Retraction Note to this paper has been published: https://doi.org/10.1007/s11095-020-02974-x…”
Get full text
Journal Article -
2
Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing
Published in PloS one (16-08-2010)“…Weak intermolecular interactions such as hydrogen bonding and hydrophobic interactions are key players in stabilizing energetically-favored ligands, in an open…”
Get full text
Journal Article -
3
Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria
Published in The Journal of biological chemistry (11-04-2003)“…There are about 2.5 million glomeruli in the kidneys each consisting of a barrel of glomerular basement membrane surrounded by glomerular endothelial cells on…”
Get full text
Journal Article -
4
Differential Protein Expression Profiling by iTRAQ−2DLC−MS/MS of Lung Cancer Cells Undergoing Epithelial-Mesenchymal Transition Reveals a Migratory/Invasive Phenotype
Published in Journal of proteome research (01-05-2006)“…Transforming growth factor-β (TGF-β) induces epithelial-mesenchymal transition (EMT) of epithelial cells in both normal embryonic development and certain…”
Get full text
Journal Article -
5
Characterization of the anti-angiogenic properties of arresten, an α1β1 integrin-dependent collagen-derived tumor suppressor
Published in Experimental cell research (01-11-2008)“…Physiological and pathological turnover of basement membranes liberates biologically active cryptic molecules. Several collagen-derived fragments possess…”
Get full text
Journal Article -
6
Function of Endogenous Inhibitors of Angiogenesis as Endothelium-Specific Tumor Suppressors
Published in Proceedings of the National Academy of Sciences - PNAS (22-02-2005)“…Disruption of the systemic angiogenesis balance to favor enhanced angiogenesis is speculated to represent a key step in the growth of tumors. Although a major…”
Get full text
Journal Article -
7
Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis
Published in Science (American Association for the Advancement of Science) (04-01-2002)“…Tumstatin is a 28-kilodalton fragment of type IV collagen that displays both anti-angiogenic and proapoptotic activity. Here we show that tumstatin functions…”
Get full text
Journal Article -
8
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
Published in The Journal of clinical investigation (01-12-2002)“…Mutations in NPHS2, encoding podocin, have been identified in childhood onset focal and segmental glomerulosclerosis (FSGS). The role of NPHS2 in adult disease…”
Get full text
Journal Article -
9
RETRACTED ARTICLE: Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression
Published in Pharmaceutical research (01-12-2008)“…Growing tumors develop additional new blood vessels to meet the demand for adequate nutrients and oxygen, a process called angiogenesis. Cancer is a highly…”
Get full text
Journal Article -
10
Regulation of COX-2–mediated signaling by α3 type IV noncollagenous domain in tumor angiogenesis
Published in Blood (15-08-2007)“…Human α3 chain, a noncollagenous domain of type IV collagen [α3(IV)NC1], inhibits angiogenesis and tumor growth. These biologic functions are partly attributed…”
Get full text
Journal Article -
11
Determinants of Vascular Permeability in the Kidney Glomerulus
Published in The Journal of biological chemistry (23-08-2002)“…The human kidneys filter 70 liters of blood plasma every day. The hallmark of almost all kidney diseases, whether acquired or genetic, is the leakage of plasma…”
Get full text
Journal Article -
12
RETRACTED ARTICLE: Inhibitory Effects of Arresten on bFGF-Induced Proliferation, Migration, and Matrix Metalloproteinase-2 Activation in Mouse Retinal Endothelial Cells
Published in Current eye research (01-01-2010)“…This article has been retracted…”
Get full text
Journal Article -
13
Molecular Cloning and Functional Characterization of Mouse α3(IV)NC1
Published in Clinical Medicine Insights. Oncology (01-01-2008)“…Chandra Shekhar Boosani1 and Akulapalli Sudhakar1,2,3 1Cell Signaling and Tumor Angiogenesis Laboratory, Department of Genetics, Boys Town National Research…”
Get full text
Journal Article -
14
Signaling Mechanisms of Endogenous Angiogenesis Inhibitors Derived from Type IV Collagen
Published in Gene Regulation and Systems Biology (01-01-2007)“…Akulapalli Sudhakar1,2,3 and Chandra S. Boosani1 1Cell Signaling and Tumor Angiogenesis Laboratory, Department of Genetics, Boys Town National Research…”
Get full text
Journal Article Book Review -
15
Human Tumstatin and Human Endostatin Exhibit Distinct Antiangiogenic Activities Mediated by αvβ3 and α5β1 Integrins
Published in Proceedings of the National Academy of Sciences - PNAS (15-04-2003)“…Tumstatin and endostatin are two inhibitors of angiogenesis derived from precursor human collagen molecules known as α3 chain of type IV collagen and α1 chain…”
Get full text
Journal Article -
16
-
17
Inhibition of Tumor Angiogenesis by Tumstatin : Insights into Signaling Mechanisms and Implications in Cancer Regression
Published in Pharmaceutical research (01-12-2008)“…Growing tumors develop additional new blood vessels to meet the demand for adequate nutrients and oxygen, a process called angiogenesis. Cancer is a highly…”
Get full text
Journal Article -
18
Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin
Published in Cancer cell (01-06-2003)“…We demonstrate a physiological role for tumstatin, a cleavage fragment of the α3 chain of type IV collagen (Col IVα3), which is present in the circulation…”
Get full text
Journal Article -
19
Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin
Published in The Journal of clinical investigation (02-01-2020)Get full text
Journal Article -
20
Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin
Published in The Journal of clinical investigation (08-09-2005)“…Human noncollagenous domain 1 of the α1 chain of type IV collagen [α1(IV)NC1], or arresten, is derived from the carboxy terminal of type IV collagen. It was…”
Get full text
Journal Article